Annexin Pharmaceuticals Financials
| ANNX Stock | SEK 0.54 0.06 12.50% |
Annexin |
Understanding current and past Annexin Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Annexin Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Annexin Pharmaceuticals' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Annexin Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Annexin Pharmaceuticals AB. Check Annexin Pharmaceuticals' Beneish M Score to see the likelihood of Annexin Pharmaceuticals' management manipulating its earnings.
Annexin Pharmaceuticals Stock Summary
Annexin Pharmaceuticals competes with Cantargia, Biovica International, Ascelia Pharma, and BioArctic. Annexin Pharmaceuticals AB , a biotechnology company, engages in developing drug candidates for the treatment of various cardiovascular diseases. The company was founded in 2014 and is based in Stockholm, Sweden. Annexin Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0009664154 |
| Business Address | Drottninggatan 65, Stockholm, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.annexinpharma.com/sv |
| Phone | 46 7 09 65 16 65 |
| Currency | SEK - Swedish Kronor |
You should never invest in Annexin Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Annexin Stock, because this is throwing your money away. Analyzing the key information contained in Annexin Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Annexin Pharmaceuticals Key Financial Ratios
Annexin Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Annexin Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Annexin Pharmaceuticals over time and compare it to other companies across industries.| Return On Equity | -1.06 | |||
| Return On Asset | -0.57 | |||
| Target Price | 2.0 | |||
| Beta | 1.55 |
Annexin Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Annexin Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Annexin Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Annexin Pharmaceuticals competition to find correlations between indicators driving Annexin Pharmaceuticals's intrinsic value. More Info.Annexin Pharmaceuticals AB is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Annexin Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Annexin Pharmaceuticals Systematic Risk
Annexin Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Annexin Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Annexin Pharmaceuticals correlated with the market. If Beta is less than 0 Annexin Pharmaceuticals generally moves in the opposite direction as compared to the market. If Annexin Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Annexin Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Annexin Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Annexin Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Annexin Pharmaceuticals November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Annexin Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Annexin Pharmaceuticals AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Annexin Pharmaceuticals AB based on widely used predictive technical indicators. In general, we focus on analyzing Annexin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Annexin Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 23.14 | |||
| Value At Risk | (6.12) | |||
| Potential Upside | 8.33 |
Additional Tools for Annexin Stock Analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.